DOD – Peer Reviewed Medical Research Program Solicitations

March 23, 2021 by dld5dt@virginia.edu

Purpose:

The Department of Defense (DOD) Congressionally Directed Medical Research Program (CDMRP) released its fiscal year (FY) 2021 Peer Reviewed Medical Research Program (PRMRP) solicitations.  For FY 2021, Congress has allocated $370 million for PRMRP in 42 topic areas.

Background:

Information on each of the funding mechanisms and a list of the FY 2021 topic areas is listed below. Those interested should carefully review the submission requirements for each funding mechanism. Additionally, interested applicants should review the “Areas of Encouragement,” in the appendix of each solicitation, for details on DOD interests in the listed topic areas.  Lewis-Burke Associates LLC (Lewis-Burke) is available to speak with those interested to provide details on best practices for successful submissions, especially as they pertain to addressing military relevancy and the review processes.

  • The Discovery Award supports the exploration of a highly innovative new concept or untested theory in the topic area(s) of interest.  Postdoctoral or clinical fellow and above are eligible.
    • Pre-Application Deadline: April 29, 2021; 5:00 PM Eastern Time (ET)
    • Solicitation details are available at www.grants.gov under solicitation number “W81XWH-21-PRMRP-DA” orhere.
  • The Focused Program Award supports multidisciplinary research with multiple investigators, addressing an overarching goal in the topic area(s) of interest.  Projects may range from exploratory/hypothesis development through small-scale clinical trials.
    • Pre-Application Deadline: May 13, 2021; 5:00 PM ET
    • Solicitation details are available at www.grants.gov under solicitation number “W81XWH-21-PRMRP-FPA” orhere.

 The Investigator-Initiated Research Award supports novel research focused on patient care and allows for partnering of primary investigators.

    • Pre-Application Deadline: April 28, 2021; 5:00 PM ET
    • Solicitation details are available at www.grants.gov under solicitation number “W81XWH-21-PRMRP-IIRA” or here.
  • The Technology/Therapeutic Development Award supports the translation of preclinical findings into clinical applications for prevention, detection, diagnosis, treatment, or quality of life in the topics area(s) of interest.  This is a product-oriented award.
    • Pre-Application Deadline: April 28, 2021; 5:00 PM ET
    • Solicitation details are available at www.grants.gov under solicitation number “W81XWH-21-PRMRP-TTDA” or here.

 The Clinical Trial Award supports the implementation of clinical trials to evaluate products, pharmacologic agents, devices, clinical guidance and emerging approaches and technologies that may significantly impact one of the diseases listed under the FY 2021 PRMRP topic areas.

    • Pre-Application Deadline: May 13, 2021; 5:00 PM ET
    • Solicitation details are available at www.grants.gov under solicitation number “W81XWH-21-PRMRP-CTA” orhere.

 Topic Areas: (* denotes new topics for FY 2021)

 

Arthritis

Burn Pit Exposure

Cardiomyopathy*

Congenital Heart Disease

Diabetes

Dystonia

Eating Disorders

Emerging Viral Diseases

Endometriosis

Epidermolysis Bullosa

Familial Hypercholesterolemia

Fibrous Dysplasia

Focal Segmental Glomerulosclerosis

Food Allergies

Fragile X

Frontotemporal Degeneration

Hemorrhage Control

Hepatitis B

Hydrocephalus

Hypertension*

Inflammatory Bowel Diseases

Malaria*

Metals Toxicology

Mitochondrial Disease

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Myotonic Dystrophy

Non-Opioid Therapy for Pain Management*

Nutrition Optimization

Pathogen-Inactivated Blood Products

Peripheral Neuropathy*

Plant-Based Vaccines

Platelet-Like Cell Production*

Polycystic Kidney Disease

Pressure Ulcers

Pulmonary Fibrosis

Respiratory Health

Rheumatoid Arthritis

Sleep Disorders and Restriction

Suicide Prevention*

Sustained Release Drug Delivery

Vascular Malformations

Women’s Heart Disease

 

 

Key Dates:

Although Congress decides which topic areas are funded, DOD program managers and Joint Program Committees (JPCs) retain authority in program directions and are influential in shaping the direction of CDMRP programs.  CDMRP employs a rigorous two-tier review process: scientific, peer review and programmatic review.  The programmatic review is intended to address the relevance of the proposed research to DOD’s needs; therefore, it is important for both the pre-application and the full proposal to consider the topic area in relation to the mission of DOD and the “Areas of Encouragement” described in the appendix of each solicitation.  Additional information about the two-tier review process is available here.

URLs for more information:

Sources and Additional Background:

 

 

 

 

Filed Under: Funding Opportunities